Home Other Building Blocks 189939-61-5
189939-61-5,MFCD04974481
Catalog No.:AA002E24
189939-61-5 | Hexadecanamide, N-(1-methylethyl)-
Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
1 week  
$98.00
- +
10mg
≥98%
1 week  
$140.00
- +
50mg
≥98%
1 week  
$430.00
- +
100mg
≥98%
1 week  
$715.00
- +
500mg
1 week  
$2,400.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA002E24
Chemical Name:
Hexadecanamide, N-(1-methylethyl)-
CAS Number:
189939-61-5
Molecular Formula:
C19H39NO
Molecular Weight:
297.5191
MDL Number:
MFCD04974481
IUPAC Name:
N-propan-2-ylhexadecanamide
InChI:
InChI=1S/C19H39NO/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(21)20-18(2)3/h18H,4-17H2,1-3H3,(H,20,21)
InChI Key:
TZYVUGCYYQOTQR-UHFFFAOYSA-N
SMILES:
CCCCCCCCCCCCCCCC(=O)NC(C)C
Properties
Computed Properties
 
Complexity:
226  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
297.303g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
297.527g/mol
Monoisotopic Mass:
297.303g/mol
Rotatable Bond Count:
15  
Topological Polar Surface Area:
29.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
7.7  

Synonyms
 
Palmitoylisopropylamide 
189939-61-5 
Tocris-1815 
N-Isopropyl-Hexadecanamide 
Palmitoyl N-Isopropylamide 
AC1NN80N 
N-ISOPROPYLHEXADECANAMIDE 
SCHEMBL1457147 
HMS3649N13 
ZINC8036050 
Hexadecanamide, N-(1-methylethyl)- 
1979AH 
N-isopropylpalmitamide 
BDBM50171292 
AKOS024456798 
RT-014931 
B6867 
FT-0673491 
J-012259 
SR-01000597539-1 
SR-01000597539-2 
C19H39NO 
CID5063962 
N-(1-Methylethyl)-hexadecanamide 
PIA 
CHEMBL32827 
Hexadecanoic acid isopropylamide 
Palmitoyl-N-isopropylamide 
SR-01000597539 
N-propan-2-ylhexadecanamide 
NCGC00025305-01 
Literature

Title: The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.

Journal: Life sciences 20060102

Title: Fatty acid amide hydrolase controls mouse intestinal motility in vivo.

Journal: Gastroenterology 20050901

Title: The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

Journal: Journal of medicinal chemistry 20050811

Title: Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20041215

Title: Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.

Journal: Journal of medicinal chemistry 20031009

Title: Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.

Journal: Journal of medicinal chemistry 20030410

Title: AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.

Journal: Archives of toxicology 20030401

Title: Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.

Journal: British journal of pharmacology 20010801

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Additional Info: